Development of New Vaccine Adjuvants

新型疫苗佐剂的开发

基本信息

  • 批准号:
    10636922
  • 负责人:
  • 金额:
    $ 18.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-06-06 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

Summary Infectious diseases remain a serious threat to human lives. According to World Health Organization, ca. 15% of all human deaths are caused by infections. To control and prevent infectious diseases, vaccination has been proved to be the most economical and effective strategy. For a vaccine to work effectively and provoke a lasting protection against a pathogen, it needs to be formulated with an adjuvant—the substance that can boost immune responses and enhance the effectiveness of vaccines. However, currently, the available choices of adjuvant are limited, and the few adjuvants that have been approved for human use are complex mixtures with largely unknow action mechanisms or restricted application scopes. More significantly, they do not exhibit sufficient efficacy for many vaccines in development. To meet the growing demands from various vaccine development and vaccination programs, it is urgent and important to improve the diversities of our toolbox of adjuvants. This project intends to address the above-mentioned issue through design and development of a novel class of adjuvants, known as “conjugate adjuvants”, which have the 2,4-nitrodiphenyl (DNP) epitope covalently coupled with monophosphoryl lipid A (MPLA). Both DNP and MPLA are very potent immunostimulants, but they boost the immune system via different mechanisms and pathways—DNP enhances immune responses through recruiting endogenous DNP antibodies naturally existing in the human serum, whilst MPLA stimulates the immune system through interactions with toll-like receptor 4. In addition, covalent conjugation of DNP with MPLA will ensure their co-localization and concerted action on and in the same immune cells, and the recruited DNP antibodies can also attract more immune cells to the vaccination site to further increase the vaccine—immune cell interaction. All these activities can help enhance the immunostimulating functions of these conjugates to show a synergistic effect and become more effective adjuvants with a broader application scope. Accordingly, a series of MPLA-DNP conjugates with DNP linked to MPLA at different positions and by different linkers are designed and will be studied in this project. Efficient synthetic methods will be developed to access these conjugates, and the synthesized MPLA-DNP conjugates will be evaluated in vitro and in mice to validate the synergistic effect and the capacities of these new adjuvants in boosting immune responses to vaccines and to gain a better understanding of the induced immune responses and the action mechanisms. If this project reaches its goal, it will result in the discovery of new and more effective adjuvants, which are applicable to not only vaccines against infectious diseases but also immunotherapies for other diseases. In addition, the innovative “conjugate adjuvant” concept will be widely applicable to other adjuvants or immunostimulants as well. The new adjuvants have well-defined structures, which will enable the investigation of their structure-activity relationships and action mechanisms. The results should be useful to guide future development of new adjuvants. Therefore, this project will have a big and broad impact on the whole field of vaccine research.
总结

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Zhongwu Guo其他文献

Zhongwu Guo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Zhongwu Guo', 18)}}的其他基金

Brain glycosphingolipids and Alzheimer's disease
脑鞘糖脂与阿尔茨海默病
  • 批准号:
    10738379
  • 财政年份:
    2023
  • 资助金额:
    $ 18.15万
  • 项目类别:
Development of New Vaccine Adjuvants
新型疫苗佐剂的开发
  • 批准号:
    10480226
  • 财政年份:
    2022
  • 资助金额:
    $ 18.15万
  • 项目类别:
Synthetic and Biological Studies of GPI Conjugates and GPI Anchorage to Cell Membranes
GPI 缀合物和 GPI 细胞膜锚定的合成和生物学研究
  • 批准号:
    9902533
  • 财政年份:
    2019
  • 资助金额:
    $ 18.15万
  • 项目类别:
Synthetic and Biological Studies of GPI Conjugates and GPI Anchorage to Cell Membranes
GPI 缀合物和 GPI 细胞膜锚定的合成和生物学研究
  • 批准号:
    10371134
  • 财政年份:
    2019
  • 资助金额:
    $ 18.15万
  • 项目类别:
Synthetic and Biological Studies of GPI Conjugates and GPI Anchorage to Cell Membranes
GPI 缀合物和 GPI 细胞膜锚定的合成和生物学研究
  • 批准号:
    10584557
  • 财政年份:
    2019
  • 资助金额:
    $ 18.15万
  • 项目类别:
New Methods to Access GPI-Anchored Proteins and Study GPI-Anchored Proteomics
获取 GPI 锚定蛋白和研究 GPI 锚定蛋白质组学的新方法
  • 批准号:
    8628408
  • 财政年份:
    2009
  • 资助金额:
    $ 18.15万
  • 项目类别:
Novel Approaches to Access GPIs and GPI-Anchored Proteins for the Study of GPI An
获取 GPI 和 GPI 锚定蛋白用于 GPI An 研究的新方法
  • 批准号:
    8324038
  • 财政年份:
    2009
  • 资助金额:
    $ 18.15万
  • 项目类别:
New Methods to Access GPI-Anchored Proteins and Study GPI-Anchored Proteomics
获取 GPI 锚定蛋白和研究 GPI 锚定蛋白质组学的新方法
  • 批准号:
    8989113
  • 财政年份:
    2009
  • 资助金额:
    $ 18.15万
  • 项目类别:
Novel Approaches to Access GPIs and GPI-Anchored Proteins for the Study of GPI An
获取 GPI 和 GPI 锚定蛋白用于 GPI An 研究的新方法
  • 批准号:
    7938107
  • 财政年份:
    2009
  • 资助金额:
    $ 18.15万
  • 项目类别:
New Methods to Access GPI-Anchored Proteins and Study GPI-Anchored Proteomics
获取 GPI 锚定蛋白和研究 GPI 锚定蛋白质组学的新方法
  • 批准号:
    9027236
  • 财政年份:
    2009
  • 资助金额:
    $ 18.15万
  • 项目类别:

相似海外基金

Single-cell analysis of adaptive immune system cells in IBD patients
IBD 患者适应性免疫系统细胞的单细胞分析
  • 批准号:
    22KJ2212
  • 财政年份:
    2023
  • 资助金额:
    $ 18.15万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Antigen presentation to the adaptive immune system in the choroid contributes to ocular autoimmune disease
脉络膜中的适应性免疫系统的抗原呈递导致眼部自身免疫性疾病
  • 批准号:
    10740465
  • 财政年份:
    2023
  • 资助金额:
    $ 18.15万
  • 项目类别:
Elucidation of the adaptive immune system in teleost fish
阐明硬骨鱼的适应性免疫系统
  • 批准号:
    22K05824
  • 财政年份:
    2022
  • 资助金额:
    $ 18.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Peripheral Adaptive Immune System Changes Associated with Alzhiemer's Disease
与阿尔茨海默病相关的外周适应性免疫系统变化
  • 批准号:
    10194864
  • 财政年份:
    2021
  • 资助金额:
    $ 18.15万
  • 项目类别:
Interaction of Galectin-9 and Pregnancy-Specific Glycoprotein 1 in the Regulation of Cells of the Innate and Adaptive Immune System
Galectin-9 和妊娠特异性糖蛋白 1 在先天性和适应性免疫系统细胞调节中的相互作用
  • 批准号:
    10434937
  • 财政年份:
    2021
  • 资助金额:
    $ 18.15万
  • 项目类别:
Interaction of Galectin-9 and Pregnancy-Specific Glycoprotein 1 in the Regulation of Cells of the Innate and Adaptive Immune System
Galectin-9 和妊娠特异性糖蛋白 1 在先天性和适应性免疫系统细胞调节中的相互作用
  • 批准号:
    10302501
  • 财政年份:
    2021
  • 资助金额:
    $ 18.15万
  • 项目类别:
Learning a molecular shape space for the adaptive immune system
学习适应性免疫系统的分子形状空间
  • 批准号:
    10275426
  • 财政年份:
    2021
  • 资助金额:
    $ 18.15万
  • 项目类别:
CAREER: Emergence of Functional Organization in the Adaptive Immune System
职业:适应性免疫系统中功能组织的出现
  • 批准号:
    2045054
  • 财政年份:
    2021
  • 资助金额:
    $ 18.15万
  • 项目类别:
    Continuing Grant
Learning a molecular shape space for the adaptive immune system
学习适应性免疫系统的分子形状空间
  • 批准号:
    10669709
  • 财政年份:
    2021
  • 资助金额:
    $ 18.15万
  • 项目类别:
Learning a molecular shape space for the adaptive immune system
学习适应性免疫系统的分子形状空间
  • 批准号:
    10467050
  • 财政年份:
    2021
  • 资助金额:
    $ 18.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了